Seoul, South Korea

Joo Youn Cho

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo Youn Cho. Retrieved from https://idiyas.com/inventor/joo-youn-cho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joo Youn Cho: Innovator in Antihypertensive Pharmaceutical Composition

Introduction

Joo Youn Cho is a notable inventor based in South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive medications. His work focuses on innovative compositions that aim to improve the treatment of hypertension.

Latest Patents

Joo Youn Cho holds a patent for an antihypertensive pharmaceutical composition. This invention includes Fimasartan, an angiotensin II receptor blocker, and Amlodipine, a calcium channel blocker. The combination of these compounds is designed to effectively manage high blood pressure.

Career Highlights

Joo Youn Cho is associated with Boryung Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His expertise in antihypertensive therapies has positioned him as a key figure in the industry.

Collaborations

He has collaborated with notable colleagues, including Seung Ho Kim and Ji Han Kim, to further enhance the efficacy of pharmaceutical compositions. Their teamwork has contributed to the innovative approaches in hypertension treatment.

Conclusion

Joo Youn Cho's work in antihypertensive pharmaceutical compositions showcases his dedication to improving healthcare solutions. His contributions are vital in the ongoing battle against hypertension, and his innovative spirit continues to inspire advancements in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…